CanVECTOR is committed to fostering a culture of Equity, Diversity, and Inclusion (EDI) within our network. Our mission, to decrease the health, social, and economic burden of VTE (Venous Thromboembolism) on affected individuals, their families, and on Canadians as a whole, underscores the importance of addressing EDI both within our network of dedicated researchers and among the patients who participate in thrombosis research studies. We believe that embracing EDI is not only ethically imperative but is also fundamental to achieving our mission by ensuring that our research is inclusive, relevant, and applicable to the diverse populations we aim to serve.

For our network members:

1. Equity: We are committed to providing equitable opportunities for all members of the CanVECTOR network, irrespective of gender, race, ethnicity, sexual orientation, disability, age, geography, religion, or any other dimension of diversity. We recognize that diverse perspectives contribute to the richness of our research endeavors and are dedicated to removing systemic barriers to inclusion.
2.  Diversity: CanVECTOR values and actively seeks diversity among our network members and leadership. We acknowledge that a diverse team fosters innovation, creativity, and a broader understanding of the complexities surrounding thrombosis. We strive to create an environment where individuals from all backgrounds feel welcome and valued.
3. Inclusion: CanVECTOR is dedicated to creating an inclusive and supportive community where every member feels heard, respected, and included. We actively promote a culture that values open communication, collaboration, and the exchange of ideas among individuals with different experiences and perspectives.

For patients participating in thrombosis research studies:

1. Equity: CanVECTOR is committed to ensuring that all patients, regardless of their background, have equitable access to participation in our research studies. We strive to eliminate barriers that may disproportionately affect certain groups, ensuring that the benefits and opportunities of research participation are accessible to everyone.
2. Diversity: We recognize the importance of including diverse patient populations in our studies to ensure that our research findings are reflective of the broader Canadian population. By actively seeking diversity in our participant pool, we enhance the generalizability and relevance of our research outcomes.
3. Inclusion: CanVECTOR is dedicated to creating a research environment that is inclusive and respectful of the unique experiences and perspectives of our patient participants. We actively seek ways to involve patients in the research process through our Patient Partners platform, ensuring that their voices are heard and valued.

In summary, CanVECTOR is committed to championing Equity, Diversity, and Inclusion both within our network and in the broader community of patients participating in thrombosis research studies. By embracing EDI principles, we aim to create a research landscape that is not only scientifically rigorous but also ethically sound, accessible, and applicable to the diverse Canadian population.